Greencoat Renewables PLC (GRP)
Irish Exchange · Ireland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 0.780 |
|---|---|
| 52-week range | 0.771 – 0.802 |
| Return, 1 month / 3 months | +1.2% / +1.2% |
| Return, 1 year / 3 years | +1.2% / −13.3% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 7.2% |
| Worst drawdown (1 year) | -2.2% |
| Average daily value traded | 0.88M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Greencoat Renewables PLC is an investment company that owns and operates renewable energy assets, chiefly onshore wind farms, in Ireland and other European countries. It generates income by selling the electricity produced by these wind farms, often under long-term power purchase agreements with utilities and corporate buyers. The company is based in Dublin and is managed by an external specialist investment manager focused on renewable energy infrastructure.
The shares are listed on the Irish Exchange in Ireland under the code GRP, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Greencoat Renewables PLC (GRP) trades on the Irish Exchange in Ireland. It last closed at EUR 0.780 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 11 of 21 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.2% and over the last three months it rose 1.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Irish Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -2.1% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.2% | ||
| 6-month return | 1.2% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 98 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 7.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -2.2% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.88M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +1.2% |
| 3 months | +1.2% |
| 6 months | +1.2% |
| 1 year | +1.2% |
| 3 years | −13.3% |
| 5 years | −22.6% |
Signals
| 50-day / 200-day average | 0.772 / 0.770 |
|---|---|
| Golden / death cross (60 days) | Golden, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.005 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2023 | EUR 0.0161 |
| 11 May 2023 | EUR 0.0161 |
| 2 Feb 2023 | EUR 0.0155 |
| 10 Nov 2022 | EUR 0.0155 |
| 4 Aug 2022 | EUR 0.0155 |
| 12 May 2022 | EUR 0.0155 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Irish Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.